EUCTR2013-001617-32-IT进行中(未招募)1 期
Thrombolysis in Minor Stroke - MINOR Study
AUSL di Piacenza0 个研究点目标入组 340 人开始时间: 2013年6月7日最近更新:
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中(未招募)
- 发起方
- 入组人数
- 340
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Acute ischemic stroke;
- •age > 18 years and < 80 years;
- •stroke symptom onset within 4.5 hours before administration of rt-PA;
- •mild stroke with an NIHSS score <5 at admission (stable or improving deficits);
- •written informed consent;
- •unknown onset strokes, with perfusion/diffusion mismatch” demonstrated by brain perfusion-Computed Tomography o diffusion/perfusion enhanced Magnetic Resonance Imaging.
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 200
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 140
排除标准
- •intracranial haemorrhage at the CT scan;
- •pregnancy or woman of childbearing age who does not take contraceptives;
- •space occupying mass at the brain CT scan;
- •unknown time of onset;
- •moderate or severe stroke with an NIHSS score of > 5;
- •ASPECT CT brain score > 7;
- •seizure at the onset of stroke with the inability to use PI-TC or RM PI-DWI. Seizures are not exclusion criteria if ischemia is demonstrated by techniques of mismatch.
- •stroke or serious head trauma within the previous 3 months;
- •the administration of heparin within 48 hours preceding the onset of the stroke, with an activated partial-thromboplastin time at presentation exceeding the upper limit for the normal range;
- •platelet count of less than 100,000/mmc;
- •a systolic pressure higher than 185 mmHg or diastolic pressure higher than 110 mmHg that cannot be corrected with appropriate therapy
- •blood glucose level lesser than 50 mg per deciliter or greater than 400 mg per deciliter;
- •symptoms suggestive of subarachnoid haemorrhage, even in the presence of a normal CT brain scan;
- •oral anticoagulant treatment and an INR score > 1.4;
- •major surgery or severe trauma within the previous 3 months;
- •other major disorders known to be associated with an increased risk of bleeding.
研究者
相似试验
已完成
不适用
Thrombolysis Register of Acute Ischaemic Stroke in ChinaISRCTN69801104Beijing Tiantan Hospital (China)330
已完成
不适用
Promoting acute thrombolysis for ischemic strokeStrokeISRCTN20405426etherlands Organisation for Health Research and Development (ZonMw)7,000
招募中
不适用
Optimal minor stroke definition for thrombolysis decision-makingDiseases of the nervous systemKCT0000679Seoul National University Bundang Hospital700
已完成
不适用
Thrombophylaxis with low-dose, short-term fondaparinux after elective hip surgeryelective hip surgeryJPRN-UMIN000010272Osaka University Graduate School of Medicine390
招募中
不适用
Interventional study on the reduction of thrombus using rivaroxaban for deep vein thrombosis and pulmonary thromboembolismvenous thromboembolismJPRN-UMIN000032996Toho University40
